Local Institution - 0137

Chūōku, Tokyo-To 104-0045

1 studies enrolling now · 1 studies all time

What they study most

Non-Small Cell Lung Cancer

Studies at this site

• Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) — Starting soon